Research

A new study demonstrates the neuroprotective properties of the supplement N-Acetylcysteine against effects of cannabis exposure in adolescence.

A recently published study found that patients using medical marijuana reported a significant increase in subjective improvements of gastrointestinal (GI) symptom severity, compared to not using medical marijuana.

This month’s Healer webinar provided a deep dive into several studies on cannabis for various conditions.

This presentation provided a comprehensive overview of cannabigerol (CBG), highlighting two studies on its effects on anxiety, stress, and pain.

A recently published study examined data on thousands of pregnancies, maternal health outcomes, and cannabis use.

This month’s webinar discussed studies conducted on cannabis and psychedelics for various conditions including anxiety and autism spectrum disorder.

Check out some of our most popular content from the first six months of the year 2024!

In continuation of our cultivation education series, Adam Jacques and Zacariah L. Hildenbrand, get to the root of the issue of experiencing an HLVd infestation and if anything can be done to salvage your crops.

The first part of this column examines the fractured nature of state-based regulations and compares it with the federal limits for pharmaceutical products and dietary supplements.

In this interview, Steve Fuhr of SciPhy Systems discusses the upcoming impacts cannabis extraction.

In this interview, Steve Fuhr of SciPhy Systems, discusses cannabis extraction methods, products, and research.

This review highlights an in-silico assessment of the binding interactions of pro-drug moiety analogs and an importance in identifying potential issues that would need further testing to ensure safety for consumers such as the hERG values which are pertinent in the pharmaceutical fields in whether or not drugs can be safe to use.

Cannabis Science Conference Spring was held in Kansas City, Missouri from May 7-9, 2024. Here, we provide highlights from this exciting event.

Let’s take a look at the most recent webinars on cannabis research and medicine to catch up on industry trends and innovations.

The smoking accessories company has partnered with the Science of Smokability study to advance research on cannabis smoking quality and consistency.

This month’s Healer webinar discussed several studies on cannabis and symptoms of dementia and cognitive decline.

This webinar discussed the research on the synergy of THC and D-limonene, discussing a study that found vaporized D-limonene reduces THC-induced anxiety.

In this research overview, Ruth Fisher, PhD, examines studies on various aspects of cannabis use and pregnancy, including effects and outcomes, risks, reasons for use, and the challenges inherent in the studies themselves.

At the Cannabis Science Conference, Antonio Timoteo Jr., PhD, presented research on cannabis cultivation practices and optimizing terpene content.

Drs. Allison Justice and Riley Kirk presents their keynote speaker presentation on Day 2 of the Cannabis Science Conference in Kansas City, Missouri, about the study they are conducting regarding the smokeability of cannabis.

During the Cannabis Science Conference Poster Session, Danielle Lenoir, program manager of Signature Science Quality Assurance Laboratory, explained how there is a gap in proficiency testing for cannabis and hemp regarding oil matrices and what is being done to bridge that gap.

Anthony Repay, Laboratory Director of Method Testing Labs, presents his talk in the Analytical Track on Day 1 of the Cannabis Science Conference in Kansas City, Missouri, about the intricacies of polysorbate 80 and how it can be used as an emulsifying agent in cannabis microbiology.

A collection of our most recent webinar coverage discussing medical research and testing methods.

This month’s Healer webinar provided a deep dive into six studies on cannabis for various conditions.

Given the fast and furious mobilization of the global healthcare community to understand the nature of the coronavirus, how to treat it, and, eventually, how to prevent it, the sheer volume of research on COVID-19 is not at all surprising. What is, perhaps, surprising, especially given how recently it’s been since the COVID-19 breakout, is that there are so many research publications on the potential for cannabis to be used to treat the virus. On the other hand, perhaps the abundance of research on cannabis for COVID-19 is not so surprising. After all, it is a virus that causes an immune response, which may escalate into a virulent inflammatory reaction. And an enormous body of research on cannabis—and cannabidiol (CBD) in particular—has shown cannabis to induce strong anti-viral and anti-inflammatory effects. It is still early days, so no clinical studies establishing the efficacy of cannabis for COVID-19 have yet been conducted, but studies have established several clear mechanisms of action for using cannabis to treat COVID-19.